Site notifications

Sub menu

 

 

Therapeutic Goods (Listing) Notice 2000 (No. 3)

Published

Published in the Commonwealth of Australia Gazette No. GN 35, 30 August 2000

Therapeutic Goods Act 1989

I, TERRY SLATER, delegate of the Parliamentary Secretary to the Minister for Health and Aged Care, under subsection 17(5) of the Therapeutic Goods Act 1989 hereby require the following therapeutic goods to be included in the part of the Australian Register of Therapeutic Goods for listed goods -

  • preparations referred to in item 3 of Schedule 4, Part 1 of the Therapeutic Goods Regulations containing as an active ingredient tocotrienols complex - palm.

Dated 14th August 2000

Terry Slater
National Manager
Therapeutic Goods Administration
Delegate of the Parliamentary Secretary

Topics

Related content

  • Therapeutic Goods (Listing) Notice 2000 (No. 1)

    Regulatory decision notices
    Listing notice - lactoferrin - bovine, colloidal anhydrous silica or silicon dioxide, glucosamine sulfate-potassium chloride complex or glucosamine sulfatesodium chloride complex, R,S- or R-alpha lipoic acid, levocarnitine, acctyllevocarnitine hydrochloride, propionyllcvocarnitine hydrochloride, levocarnitine hydrochloride, levocarnitine tartrate, levocarnitine fumarate or levocarnitine magnesium citrate, bromclain, lecithin, soy -soy phosphatidylserine-enriched